Literature DB >> 30615787

Katayama Syndrome Without Schistosoma mansoni Eggs.

Marijke C C Langenberg1, Marie-Astrid Hoogerwerf1, Jacqueline J Janse1, Lisette van Lieshout1, Paul L A M Corstjens1, Meta Roestenberg1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30615787     DOI： 10.7326/L18-0438

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  9 in total

Review 1.  Effects of helminths on the human immune response and the microbiome.

Authors:  P'ng Loke; Soo Ching Lee; Oyebola O Oyesola
Journal:  Mucosal Immunol       Date:  2022-06-22       Impact factor: 7.313

2.  A controlled human Schistosoma mansoni infection model to advance novel drugs, vaccines and diagnostics.

Authors:  Marie-Astrid Hoogerwerf; Jan Pieter R Koopman; Marijke C C Langenberg; Jacqueline J Janse; Janneke Kos-van Oosterhoud; Carola Feijt; Simon P Jochems; Claudia J de Dood; Roos van Schuijlenburg; Arifa Ozir-Fazalalikhan; Mikhael D Manurung; Erliyani Sartono; Martha T van der Beek; Béatrice M F Winkel; Petra H Verbeek-Menken; Koen A Stam; Fijs W B van Leeuwen; Pauline Meij; Angela van Diepen; Lisette van Lieshout; Govert J van Dam; Paul L A M Corstjens; Cornelis H Hokke; Maria Yazdanbakhsh; Leo G Visser; Meta Roestenberg
Journal:  Nat Med       Date:  2020-02-17       Impact factor: 53.440

Review 3.  Circulating Anodic Antigen (CAA): A Highly Sensitive Diagnostic Biomarker to Detect Active Schistosoma Infections-Improvement and Use during SCORE.

Authors:  Paul L A M Corstjens; Claudia J de Dood; Stefanie Knopp; Michelle N Clements; Giuseppina Ortu; Irenee Umulisa; Eugene Ruberanziza; Udo Wittmann; Thomas Kariuki; Philip LoVerde; William Evan Secor; Lydia Atkins; Safari Kinung'hi; Sue Binder; Carl H Campbell; Daniel G Colley; Govert J van Dam
Journal:  Am J Trop Med Hyg       Date:  2020-07       Impact factor: 2.345

4.  Money-oriented risk-takers or deliberate decision-makers: a cross-sectional survey study of participants in controlled human infection trials.

Authors:  Marie-Astrid Hoogerwerf; Martine de Vries; Meta Roestenberg
Journal:  BMJ Open       Date:  2020-07-26       Impact factor: 2.692

5.  Risk assessment for the implementation of controlled human Schistosoma mansoni infection trials in Uganda.

Authors:  Meta Roestenberg; Alison M Elliott; Jan Pieter Koopman; Moses Egesa; Anne Wajja; Moses Adriko; Jacent Nassuuna; Gyaviira Nkurunungi; Emmanuella Driciru; Gijsbert van Willigen; Stephen Cose; Maria Yazdanbakhsh; Pontiano Kaleebu; Narcis Kabatereine; Edridah Tukahebwa
Journal:  AAS Open Res       Date:  2019-08-13

Review 6.  Schistosomes in the Lung: Immunobiology and Opportunity.

Authors:  Emma L Houlder; Alice H Costain; Peter C Cook; Andrew S MacDonald
Journal:  Front Immunol       Date:  2021-04-19       Impact factor: 7.561

7.  Characterisation of tetraspanins from Schistosoma haematobium and evaluation of their potential as novel diagnostic markers.

Authors:  Gebeyaw G Mekonnen; Bemnet A Tedla; Mark S Pearson; Luke Becker; Matt Field; Abena S Amoah; Govert van Dam; Paul L A M Corstjens; Takafira Mduluza; Francisca Mutapi; Alex Loukas; Javier Sotillo
Journal:  PLoS Negl Trop Dis       Date:  2022-01-24

8.  Sex-Specific Modulation of the Host Transcriptome in the Spleen of Schistosoma mansoni-Infected Mice.

Authors:  Franziska Winkelmann; Anne Rabes; Cindy Reinholdt; Nicole Koslowski; Dirk Koczan; Emil C Reisinger; Martina Sombetzki
Journal:  Front Cell Infect Microbiol       Date:  2022-07-05       Impact factor: 6.073

9.  Ultraviolet disinfection of Schistosoma mansoni cercariae in water.

Authors:  Lucinda Hazell; Fiona Allan; Aidan M Emery; Michael R Templeton
Journal:  PLoS Negl Trop Dis       Date:  2021-07-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.